0000000000388589

AUTHOR

Rita Alaggio

0000-0003-3915-3816

showing 5 related works from this author

Malignant germ cell tumors in childhood: results of the first Italian cooperative study "TCG 91".

2003

Background and Aims About 20% of patients with germ cell tumor (GCT) are still resistant to therapy. To investigate which features are present in resistant patients, a multicenter study on GCT in children was undertaken to correlate clinical and laboratory parameters with the outcome. Methods Patients aged less than 16 years, with histologically proven extracranial GCT were included. Results Ninety-five patients (median age 33 months, 45 males) were eligible. The site of the primary tumor was gonadal in 59, extragonadal in 36. The stage was I in 39; II in 5; IIIa (microscopic residue) in 7; IIIb (macroscopic residue) in 16; IIIc (unresectable) in 13; IV in 15. The treatment was surgery alon…

MaleCancer Researchmedicine.medical_treatmentGastroenterologyCohort Studieschemistry.chemical_compoundChildmalignant germ cell tumorsEtoposideOvarian NeoplasmsIfosfamideIncidenceseminomaPrognosisCombined Modality TherapyPrimary tumorChemotherapy regimenTreatment OutcomeItalyOncologyChild PreschoolcarboplatinFemaleGerminomamedicine.drugmedicine.medical_specialtyAdolescentRisk Assessmentrisk factors in malignant germ cellAge Distributioncarboplatin; malignant germ cell tumors; risk factors in malignant germ cell; seminomaTesticular NeoplasmsInternal medicineConfidence IntervalsmedicineHumansSex DistributionSurvival analysisNeoplasm StagingProbabilityRetrospective StudiesChemotherapybusiness.industrySeminomamedicine.diseaseSurvival AnalysisCarboplatinSurgerychemistryMultivariate AnalysisPediatrics Perinatology and Child Healthbusiness
researchProduct

Bax mutation and overexpression inversely correlate with immature phenotype and prognosis of childhood germ cell tumors

2007

Primary childhood germ cell tumors (GCTs) represent a rare and heterogeneous group of tumors that varies in histologic differentiation, age of presentation and clinical outcome. In malignant neoplasms, apoptosis is a prognostic marker and a predictive factor of response to therapy. Therefore, the study of the expression and mutation of molecules involved in the regulation of apoptosis could be useful in order to both predict the clinical outcome and design self-tailored therapeutic approaches. We retrospectively analysed tissue samples of 54 childhood GCTs. The expression of p53 and BAX protein was assessed by immunohistochemistry (IHC). Moreover, we investigated the presence of mutations i…

MaleCancer ResearchPathologymedicine.medical_specialtyAdolescentBcl-2-associated X proteinmedicineHumansChildRetrospective Studiesbcl-2-Associated X ProteinOncogenebiologyImmunochemistryInfant NewbornCancerInfantGeneral MedicineCell cycleNeoplasms Germ Cell and Embryonalmedicine.diseaseGenes p53PrognosisMolecular medicinePhenotypeOncologyChild PreschoolMutationbiology.proteinImmunohistochemistryImmature teratomaFemaleGerm cell tumorsTumor Suppressor Protein p53
researchProduct

Fibrosarcoma in pediatric patients: Results of the Italian Cooperative Group Studies (1979-1995)

2001

Background and Objectives Fibrosarcoma is a rare soft tissue sarcoma (STS) that has two peaks of incidence in pediatric patients: one in infants and young childern (infantile fibrosarcoma), another in older children (“adult type” fibrosarcoma). The purpose of this study was to describe the clinical features and the treatment results in patients affected by fibrosarcoma enrolled in two consecutive studies run by the STS-Italian Cooperative Group (ICG) between 1979 and 1995. Patients and Methods Twenty-five evaluable patients were grouped according the intergroup rhabdomyosarcoma staging (IRS) system: 12 Gr I, 5 Gr II, 8 Gr III. The cut-off point between the two forms was considered the age o…

Malemedicine.medical_specialtyinfantile fibrosarcomaAdolescentmedicine.medical_treatmentSoft Tissue NeoplasmsSettore MED/38 - Pediatria Generale E SpecialisticamedicineHumansFibrosarcomaRhabdomyosarcomaChildSurvival analysisfibrosarcoma; infantile fibrosarcoma; soft tissue sarcomabusiness.industrySoft tissue sarcomaSettore MED/20 - Chirurgia Pediatrica E InfantileAge FactorsInfantRadiotherapy DosageSarcomaGeneral Medicinemedicine.diseaseCombined Modality TherapySurvival AnalysisSurgeryRadiation therapyTreatment OutcomeOncologyChild Preschoolsoft tissue sarcomaSurgeryFemalefibrosarcomaSarcomaInfantile FibrosarcomabusinessProgressive disease
researchProduct

Fibrous hamartoma of infancy: an Italian multi-institutional experience.

2006

Fibrous hamartoma of infancy: an Italian multi-institutional experience. Carretto E, Dall'Igna P, Alaggio R, Siracusa F, Granata C, Ferrari A, Cecchetto G. Source Division of Paediatric Surgery, Department of Paediatrics, University of Padua, Padua, Italy. Abstract BACKGROUND: Fibrous hamartoma (FH) of infancy is a benign mesenchymal tumor, occurring as a superficial mass. Complete excision is curative. OBJECTIVE AND METHODS: The clinical features and treatment results of 18 children with FH are described. RESULTS: Local excision was the most common procedure. Surgery was radical in 10 patients, with microscopic residual disease in 6; all of them are alive with no evidence of disease 2 to 4…

Malemedicine.medical_specialtymedicine.medical_treatmentBiopsyHamartomaDermatologyDiseaseSkin DiseasesLesionBiopsymedicineFibrous hamartomaHumansChildChemotherapymedicine.diagnostic_testbusiness.industryInfant NewbornInfantLabia majoraSurgeryPlastic surgerymedicine.anatomical_structureTreatment OutcomeItalyChild PreschoolFemalemedicine.symptombusinesspaediatric surgery paediatric tumours fibrohamartomaFibrous hamartoma of infancyJournal of the American Academy of Dermatology
researchProduct

Focal nodular hyperplasia of the liver: an unusual association with diabetes mellitus in a child and review of literature

2010

Abstract Hepatic hemangioma, adenoma and focal nodular hyperplasia are the most frequent benign lesions of the liver, but they are all infrequent among pediatric population. The reports of focal nodular hyperplasia in children have recently increased in number, with many cases associated to drug intake, particularly to chemotherapy. We here describe, to our knowledge, the first case of focal nodular hyperplasia in association with diabetes mellitus in childhood.

MalePathologymedicine.medical_specialtyAdenomamedicine.medical_treatmentBiopsyDiagnosis DifferentialBiliary atresiaDiabetes mellitusBiopsyCase reportmedicineHepatectomyHumansChildChemotherapymedicine.diagnostic_testbusiness.industryFocal nodular hyperplasialcsh:RJ1-570lcsh:Pediatricsmedicine.diseaseDiabetes Mellitus Type 1Focal Nodular HyperplasiaDifferential diagnosisHepatectomybusinessTomography X-Ray ComputedFollow-Up Studies
researchProduct